Morbidity after insertion of totally implantable venous access ports in oncological patients: results of a retrospective clinical study

Am Surg. 2014 Feb;80(2):204-7.

Authors

Manuela Aspalter¹, Michael Lechner, Klaus Linni, Wolfgang Hitzl, Thomas Hölzenbein, Dietmar Ofner, Klaus Emmanuel

Affiliation

¹ Department of Surgery and the Department of Vascular and Endovascular Surgery, Paracelsus Medical University, Salzburg, Austria.

PMID: 24480224

No abstract available

Publication types

Comparative Study
Evaluation Study

MeSH terms

Antineoplastic Agents / administration & dosage
Catheter-Related Infections / diagnosis
Catheter-Related Infections / epidemiology*
Catheterization, Central Venous / adverse effects*
Catheterization, Central Venous / methods
Catheters, Indwelling / adverse effects
Cohort Studies
Constriction, Pathologic / epidemiology*
Constriction, Pathologic / etiology
Equipment Failure
Female
Follow-Up Studies
Humans
Incidence
Male
Multivariate Analysis
Neoplasms / drug therapy*
Odds Ratio
Pneumothorax / epidemiology
Pneumothorax / etiology
Retrospective Studies
Risk Assessment
Subclavian Vein
Vascular Access Devices / adverse effects*

Substances

Antineoplastic Agents